Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in sepsis and septic shock

  • Symposium on Advances in Therapy
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Sepsis remains a common problem in all age groups. Recently surviving sepsis campaign has taken up a worldwide initiative by publishing international guidelines 2008 with a hope to disseminate information regarding management of sepsis for all age groups. This article presents a review of recent advances as they apply to pediatric age group supported by the available evidence with reference to standard definitions of pediatric sepsis and septic shock and management in the emergency room and pediatric intensive care unit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bone RC, Balk RA, Cerra FB. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis THE ACCP/SCCM consensus conference committee. Chest 1992; 101: 1644–1655.

    Article  PubMed  CAS  Google Scholar 

  2. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2–8.

    Article  PubMed  Google Scholar 

  3. Dellinger RP, Carlet JM, Masur H. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858–873.

    Article  PubMed  Google Scholar 

  4. Dellinger RP, Levy MM, Carlet JM et al. For the International Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. 2008 Crit Care Med 2008; 36: 296–327.

    Article  Google Scholar 

  5. Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30: 1365–1378.

    Article  PubMed  Google Scholar 

  6. Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003; 112: 793–799.

    Article  PubMed  Google Scholar 

  7. Ninis N, Phillips C, Bailey L, Pollock JI, Nadel S, Britto J et al. The role of healthcare delivery on outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ 2005; 330: 1475–1482.

    Article  PubMed  Google Scholar 

  8. Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A, et al. Meningococcal Research Group. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001; 85: 386–390.

    Article  PubMed  CAS  Google Scholar 

  9. Kutko MC, Calarco MP, Flaherty MB, Helmrich RF, Ushay HM, Pon S et al. Mortality rates in pediatric septic shock with and without multiple organ failure. Pediatr Crit Care Med 2003; 4: 333–337.

    Article  PubMed  Google Scholar 

  10. Karapinar B, Lin JC, Carcillo JA. ACCM guidelines use, correct antibiotic therapy, and immune suppressant withdrawal are associated with improved survival in pediatric sepsis, severe sepsis, and septic shock. Crit Care Med 2004; 32: 573.

    Google Scholar 

  11. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT et al. Comparison of the three fluid solutions for resuscitation in dengue shock. N Engl J Med 2005; 353: 877–889.

    Article  PubMed  Google Scholar 

  12. Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria:preliminary evidence of albumin benefit. Clin Infect Dis 2005; 40: 538–545.

    Article  PubMed  Google Scholar 

  13. Nhan NT, Phuong CXT, Kneen R. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001; 32: 204–212.

    Article  Google Scholar 

  14. Ranjit S, Kissoon N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: A suggested protocol. Pediatr Crit Care Med 2005; 6: 412–419.

    Article  PubMed  Google Scholar 

  15. Ceneviva G, Paschall JA, Maffei F. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998; 102: e19.

    Article  PubMed  CAS  Google Scholar 

  16. De Kleijn ED, Joosten KF, Van Rijn B. Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 2002; 21: 330–336.

    Article  PubMed  Google Scholar 

  17. Riordan FA, Thomson AP, Ratcliffe JM. Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency? Crit Care Med 1999; 27: 2257–2261.

    Article  PubMed  CAS  Google Scholar 

  18. Min MU, Aye M. Hydrocortisone in the management of dengue shock syndrome. Southeast Asian J Trop Med Public Health 1975; 6: 573–579.

    PubMed  CAS  Google Scholar 

  19. Sumarm O, Talogo W, Asrin A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69: 45–49.

    Google Scholar 

  20. Barton P, Garcia J, Kouatli. Hemodynamic effects of intravenous milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebocontrolled, interventional study. Chest 1996; 109: 1302–1312.

    Article  PubMed  CAS  Google Scholar 

  21. Lindsay CA, Barton P, Lawless S et al. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 1998; 132: 329–334.

    Article  PubMed  CAS  Google Scholar 

  22. Paradsis M, Evans N, Kluckow M, Osborn D, Maclachlan AJ Pilot study of milrinone for low sysyemic blood flow in very preterm infants. J Pediatr 2006 148: 306–313.

    Article  CAS  Google Scholar 

  23. Irazusta JE, Pretzlaff RK, Rowin ME. Amrinone in pediatric refractory shock: An open label pharmacodynamic study. Pediatr Crit Care Med 2001; 2: 24–28.

    Article  Google Scholar 

  24. Sorenson GK, Ramamoorthy C, Lynn AM. Hemodynamic effects of amrinone in children after Fontan surgery. Anesth and Analg 1996; 82: 241–246

    Article  Google Scholar 

  25. Chang AC, Atz AM, Wernovsky G. Milrinone: systemic and pulmonary hemodynamics effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907–1914.

    Article  PubMed  CAS  Google Scholar 

  26. Carcillo JA, Pollack MM, Ruttimann UE. Sequential physiologic interactions in cardiogenic and septic shock. Crit Care Med 1989; 17: 6–12.

    Article  Google Scholar 

  27. Rivers E, Nguyen B, Havstad. Early goal directed therapy in the treatment of Severe Sepsis and Septic Shock. New Engl J Med 2001; 346: 1368–1377.

    Article  Google Scholar 

  28. Matejovic M, Krouzecky A, Radej J, Novak I. Successful reversal of resistant hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 2005; 49: 127–128.

    Article  PubMed  CAS  Google Scholar 

  29. Noto A, Giacomini M, Palandi A, Stabile L, Reali-Forster C, Iapichino G. Levosimendan in septic cardiac failure. Intensive Care Med 2005; 31: 164–165.

    Article  PubMed  CAS  Google Scholar 

  30. Morelli A, Teboul JL, Maggiore SM, Viellard-Baron A, Rocco M, Conti G. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006; 34: 2287–2293.

    Article  PubMed  CAS  Google Scholar 

  31. Muller K, Peters A, Zeus T, Hennersdorf M, Strauer BE. Therapy of acute decompensated heart failure with levosimendan. Med Klin 2006; 101: 119–122.

    Google Scholar 

  32. Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS. Early experience with Levosimendan in children with ventricular dysfunction. Pediatr Crit Care 2006; 7: 445–448.

    Article  Google Scholar 

  33. Ringe HI, Varnholt V, Gaedicke G. Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediat Crit Care Med 2003; 4: 471–475.

    Article  Google Scholar 

  34. Kern H, Schroder T, Kaulfuss M, Martin M, Kox WJ, Spies CD. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid optimized septic shock patients. Crit Care Med 2001; 29: 1519–1525

    Article  PubMed  CAS  Google Scholar 

  35. Holmes CL, Patel BM, Russell JA. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989–1002.

    Article  PubMed  CAS  Google Scholar 

  36. Jackson E. Vasopressin and other agents affecting the renal conservation of water. In Hardman JG, Limbird LE ed. Goodman and Gilman’s the pharmacological basis of therapeutics. New York; McGraw Hill, 2001.

  37. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Eng J Med 2001; 345: 588–595.

    Article  CAS  Google Scholar 

  38. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Hemodynamic and metabolic effects of low dose vasopressin infusion in vasodilatory Septic shock. Crit Care Med 2001; 29: 487–493.

    Article  PubMed  CAS  Google Scholar 

  39. O’Brien A, Clapp L, Singer M. Terlipressin for nor epinephrine resistant shock. Lancet 2002; 359: 1209–1210.

    Article  PubMed  CAS  Google Scholar 

  40. Yunge M, Petros A. Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000; 82: 388–389.

    Article  PubMed  CAS  Google Scholar 

  41. Gregory JS, Binfiglio NF, Dasta JF. Experience with phenylephrine as a component of pharmacologic support of septic shock. Crit Care Med 1991; 19: 1340–1395.

    Article  Google Scholar 

  42. Redl-Wenzl EM, Armbruster C, Edelman G. The effects of norepinephrine on hemodynamics and renal function in severe septic shock. Intensive Care Med 1993; 19: 151–154.

    Article  PubMed  CAS  Google Scholar 

  43. Meadows D, Edwards JD, Wilkins RG. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16: 663–666.

    Article  PubMed  CAS  Google Scholar 

  44. Desjars P, Pinaud M, Potel G. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15: 134–137.

    Article  PubMed  CAS  Google Scholar 

  45. Rosenzweig EB, Starc TJ, Chen JM. Intravenous argininevasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100: 182–186.

    CAS  Google Scholar 

  46. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31: 2646–2650.

    Article  PubMed  CAS  Google Scholar 

  47. Delmas A, Leone M, Rousseau S, Albanese J, Martin C. Vasopressin and terlipressin in septic shock patients. Critical Care 2005; 9: 212–222.

    Article  PubMed  Google Scholar 

  48. Leibovitch L, Efrati O, Vardi A, Matok I, Barzilay Z, Paret G. Intractable hypotension in septic shock: successful treatment with vasopressin in an infant. Israel Med Assoc J 2003; 5: 596–598.

    Google Scholar 

  49. Liedel JL, Meadow W, Nachman J, Koogler T, Kahana MD. Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature. Pediatr Crit Care Med 2002; 3: 8–15.

    Article  Google Scholar 

  50. Vasudevan A, Lodha R, Kabra SK. Vasopressin infusion in children with catecholamine-resistant septic shock. Acta Pediatric 2005; 94: 380–383.

    CAS  Google Scholar 

  51. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, Gonzalez-Alonso N, Martinon-Sanchez JM. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004; 30: 477–480.

    Article  PubMed  Google Scholar 

  52. Matok I, Vard A, Efrati O, Rubinshtein M, Vishne T, Leibovitch L et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 2005; 23: 305–310.

    Article  PubMed  CAS  Google Scholar 

  53. Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5: 116–118.

    Article  PubMed  Google Scholar 

  54. Peters MJ, Booth RA, Petros AJ. Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatr Crit Care Med 2004; 5: 188–189.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Pediatric Sciences, Central India’s Child Hospital and Research Institute, Nagpur, India

    Satish Deopujari

  2. Pediatric Critical Care Unit, Pittsburgh Children Hospital, Pittsburgh, USA

    Joe Carcillo

  3. MAX Superspeciality Hospital, New Delhi, USA

    Praveen Khilnani

Authors
  1. Praveen Khilnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satish Deopujari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joe Carcillo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Praveen Khilnani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khilnani, P., Deopujari, S. & Carcillo, J. Recent advances in sepsis and septic shock. Indian J Pediatr 75, 821–830 (2008). https://doi.org/10.1007/s12098-008-0154-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-008-0154-y

Key words

Search

Navigation